| Home > Publications Database > Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease. |
| Journal Article | DZNE-2024-00035 |
; ; ; ; ; ; ; ; ; ; ; ; ; ;
2024
Nature Publishing Group UK
[London]
This record in other databases:
Please use a persistent id in citations: doi:10.1038/s41467-023-44374-w
Abstract: In Alzheimer's disease, amyloid-beta (Aβ) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to promote tau spreading. Aβ induces aberrant synaptic activity, manifesting in increases in the presynaptic growth-associated protein 43 (GAP-43), which is closely involved in synaptic activity and plasticity. We therefore tested whether Aβ-related GAP-43 increases, as a marker of synaptic changes, drive tau spreading in 93 patients across the aging and Alzheimer's spectrum with available CSF GAP-43, amyloid-PET and longitudinal tau-PET assessments. We found that (1) higher GAP-43 was associated with faster Aβ-related tau accumulation, specifically in brain regions connected closest to subject-specific tau epicenters and (2) that higher GAP-43 strengthened the association between Aβ and connectivity-associated tau spread. This suggests that GAP-43-related synaptic changes are linked to faster Aβ-related tau spread across connected regions and that synapses could be key targets for preventing tau spreading in Alzheimer's disease.
Keyword(s): Humans (MeSH) ; Alzheimer Disease: metabolism (MeSH) ; GAP-43 Protein: genetics (MeSH) ; GAP-43 Protein: metabolism (MeSH) ; tau Proteins: metabolism (MeSH) ; Amyloid beta-Peptides: metabolism (MeSH) ; Brain: metabolism (MeSH) ; Positron-Emission Tomography (MeSH) ; Cognitive Dysfunction: metabolism (MeSH) ; Biomarkers: metabolism (MeSH) ; GAP-43 Protein ; tau Proteins ; Amyloid beta-Peptides ; Biomarkers
|
The record appears in these collections: |